WEITZMAN DEBORAH (CEO, Pharmaceutical Segment) received a stock award from CARDINAL HEALTH INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/18/2026ACC: 0001942639-26-000002
Officer· CEO, Pharmaceutical Segment
Since Sep 2022
-22.45K
Net shares
Net seller
$7.00M
Total sold
0
Open market trades
0B · 0S
2
Total transactions
7.31K acquired · 29.76K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+7.31K
Price / share
—
Trade value
—
% of position
6.8%
8/15/2026
107.70K→115.01K
Common Shares
Direct
Shares
−29.76K
Price / share
$235.17
Trade value
$7M
% of position
25.9%
8/15/2026
115.01K→85.25K
Total
Net shares
−22.45K
Net value
-$7M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 8/15/2026 | A · Award | +7.31K | — | — | 6.8% | 107.70K | 115.01K |
| Common Shares Direct | 8/15/2026 | F · Tax Withholding | −29.76K | $235.17 | $7M | 25.9% | 115.01K | 85.25K |
| Total | −22.45K | -$7M | ||||||
Derivative Transactions0
No derivative transactions reported